1. Home
  2. PHAR vs ADTN Comparison

PHAR vs ADTN Comparison

Compare PHAR & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ADTN
  • Stock Information
  • Founded
  • PHAR 1988
  • ADTN 1985
  • Country
  • PHAR Netherlands
  • ADTN United States
  • Employees
  • PHAR N/A
  • ADTN N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ADTN Telecommunications Equipment
  • Sector
  • PHAR Health Care
  • ADTN Telecommunications
  • Exchange
  • PHAR Nasdaq
  • ADTN Nasdaq
  • Market Cap
  • PHAR 627.5M
  • ADTN 639.4M
  • IPO Year
  • PHAR N/A
  • ADTN 1994
  • Fundamental
  • Price
  • PHAR $8.18
  • ADTN $7.75
  • Analyst Decision
  • PHAR Strong Buy
  • ADTN Strong Buy
  • Analyst Count
  • PHAR 2
  • ADTN 3
  • Target Price
  • PHAR $33.50
  • ADTN $10.50
  • AVG Volume (30 Days)
  • PHAR 6.6K
  • ADTN 689.1K
  • Earning Date
  • PHAR 10-24-2024
  • ADTN 11-06-2024
  • Dividend Yield
  • PHAR N/A
  • ADTN N/A
  • EPS Growth
  • PHAR N/A
  • ADTN N/A
  • EPS
  • PHAR N/A
  • ADTN N/A
  • Revenue
  • PHAR $285,745,000.00
  • ADTN $905,347,000.00
  • Revenue This Year
  • PHAR $20.89
  • ADTN N/A
  • Revenue Next Year
  • PHAR $11.15
  • ADTN $11.07
  • P/E Ratio
  • PHAR N/A
  • ADTN N/A
  • Revenue Growth
  • PHAR 30.64
  • ADTN N/A
  • 52 Week Low
  • PHAR $6.65
  • ADTN $4.34
  • 52 Week High
  • PHAR $13.20
  • ADTN $8.29
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 47.63
  • ADTN 70.04
  • Support Level
  • PHAR $7.70
  • ADTN $7.89
  • Resistance Level
  • PHAR $8.28
  • ADTN $8.29
  • Average True Range (ATR)
  • PHAR 0.41
  • ADTN 0.36
  • MACD
  • PHAR -0.07
  • ADTN 0.13
  • Stochastic Oscillator
  • PHAR 44.27
  • ADTN 76.21

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.

Share on Social Networks: